Skip to main content
Top
Published in: Abdominal Radiology 1/2013

01-02-2013

Local colorectal cancer recurrence: pelvic MRI evaluation

Authors: A. Colosio, P. Fornès, P. Soyer, M. Lewin, M. Loock, C. Hoeffel

Published in: Abdominal Radiology | Issue 1/2013

Login to get access

Abstract

Surveillance of colorectal cancer is currently based on dosage of tumoral markers, colonoscopy and multidetector row computed tomography. However, pelvic magnetic resonance imaging (MRI) and PET–CT are two second-line useful imaging modalities to assess colorectal cancer local recurrence (LR). The anatomical information derived from MRI combined to the functional information provided by diffusion-weighted imaging currently remain of value. Pelvic MRI is accurate not only for detection of pelvic colorectal recurrence but also for the prediction of absence of tumoral invasion in pelvic structures, and it may thus provide a preoperative road map of the recurrence to allow for appropriate surgical planning. As always, correlation of imaging and clinical findings in the multidisciplinary forum is paramount. MRI can also be used to follow-up LR treated with radiofrequency ablation. The aim of this review is to discuss clinical practice and application of MRI in the assessment or pelvic recurrence from colorectal cancer.
Literature
1.
go back to reference Abulafi AM, William NS (1994) The local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy. Br J Surg 81:7–19PubMedCrossRef Abulafi AM, William NS (1994) The local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy. Br J Surg 81:7–19PubMedCrossRef
2.
go back to reference Turk PS, Wanebo HJ (1993) Results of surgical treatment of nonhepatic recurrence of colorectal carcinoma. Cancer 71:4267–4277PubMedCrossRef Turk PS, Wanebo HJ (1993) Results of surgical treatment of nonhepatic recurrence of colorectal carcinoma. Cancer 71:4267–4277PubMedCrossRef
3.
go back to reference Hahnloser D, Nelson H, Gunderson LL, et al. (2003) Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg 237:502–508PubMed Hahnloser D, Nelson H, Gunderson LL, et al. (2003) Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg 237:502–508PubMed
4.
go back to reference Bedrosian I, Giacco G, Pederson L, et al. (2006) Outcome after curative resection for locally recurrent rectal cancer. Dis Colon Rectum 49:175–182PubMedCrossRef Bedrosian I, Giacco G, Pederson L, et al. (2006) Outcome after curative resection for locally recurrent rectal cancer. Dis Colon Rectum 49:175–182PubMedCrossRef
5.
go back to reference Dresen RC, Gosens MJ, Martijn H, et al. (2008) Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol 15:1937–1947PubMedCrossRef Dresen RC, Gosens MJ, Martijn H, et al. (2008) Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol 15:1937–1947PubMedCrossRef
6.
go back to reference Valentini V, Morganti AG, Gambacorta MA, et al. (2006) Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Int J Radiat Oncol Biol Phys 64:1129–1139PubMedCrossRef Valentini V, Morganti AG, Gambacorta MA, et al. (2006) Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Int J Radiat Oncol Biol Phys 64:1129–1139PubMedCrossRef
7.
go back to reference Boyle KM, Sagar PM, Chalmers AG, et al. (2005) Surgery for locally recurrent rectal cancer. Dis Colon Rectum 48:929–937PubMedCrossRef Boyle KM, Sagar PM, Chalmers AG, et al. (2005) Surgery for locally recurrent rectal cancer. Dis Colon Rectum 48:929–937PubMedCrossRef
8.
go back to reference Van Cutsem E, Nordlinger B, Cervantes A, et al. (2010) Advanced colorectal cancer: ESMO clinical practice guidelines for treatment. Ann Oncol 21(Suppl 5):93–97CrossRef Van Cutsem E, Nordlinger B, Cervantes A, et al. (2010) Advanced colorectal cancer: ESMO clinical practice guidelines for treatment. Ann Oncol 21(Suppl 5):93–97CrossRef
9.
go back to reference Enríquez-Navascués JM, Borda N, Lizerazu A, et al. (2011) Patterns of local recurrence in rectal cancer after a multidisciplinary approach. World J Gastroenterol 17:1674–1684PubMedCrossRef Enríquez-Navascués JM, Borda N, Lizerazu A, et al. (2011) Patterns of local recurrence in rectal cancer after a multidisciplinary approach. World J Gastroenterol 17:1674–1684PubMedCrossRef
10.
go back to reference Quirke P, Steele R, Monson J, et al. (2009) Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 373:821–828PubMedCrossRef Quirke P, Steele R, Monson J, et al. (2009) Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 373:821–828PubMedCrossRef
11.
go back to reference Guillem JG, Minsky BD (2008) Extended perineal resection of distal rectal cancers: surgical advance, increased utilization of neoadjuvant therapies, proper patient selection or all of the above? J Clin Oncol 26:3481–3482PubMedCrossRef Guillem JG, Minsky BD (2008) Extended perineal resection of distal rectal cancers: surgical advance, increased utilization of neoadjuvant therapies, proper patient selection or all of the above? J Clin Oncol 26:3481–3482PubMedCrossRef
12.
go back to reference Kusters M, Marijnen CA, van de Velde CJ, et al. (2010) Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol 36:470–476PubMedCrossRef Kusters M, Marijnen CA, van de Velde CJ, et al. (2010) Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol 36:470–476PubMedCrossRef
13.
go back to reference Titu LV, Nicholson AA, Hartley JE, Breen DJ, Monson JR (2006) Routine follow-up by magnetic resonance imaging does not improve detection of resectable local recurrences from colorectal cancer. Ann Surg 243:348–352PubMedCrossRef Titu LV, Nicholson AA, Hartley JE, Breen DJ, Monson JR (2006) Routine follow-up by magnetic resonance imaging does not improve detection of resectable local recurrences from colorectal cancer. Ann Surg 243:348–352PubMedCrossRef
14.
go back to reference Maas M, Rutten IJ, Nelemans PJ, et al. (2011) What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis: imaging for recurrent colorectal cancer. Eur J Nucl Med Mol Imaging 38:1560–1571PubMedCrossRef Maas M, Rutten IJ, Nelemans PJ, et al. (2011) What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis: imaging for recurrent colorectal cancer. Eur J Nucl Med Mol Imaging 38:1560–1571PubMedCrossRef
15.
go back to reference Schmidt GP, Baur-Melnyk A, Haug A, et al. (2009) Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer. Eur Radiol 19:1366–1378PubMedCrossRef Schmidt GP, Baur-Melnyk A, Haug A, et al. (2009) Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer. Eur Radiol 19:1366–1378PubMedCrossRef
16.
go back to reference Even-Sapir E, Parag Y, Lerman H, et al. (2004) Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 232:815–822PubMedCrossRef Even-Sapir E, Parag Y, Lerman H, et al. (2004) Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 232:815–822PubMedCrossRef
17.
go back to reference Von Schulthess GK, Steinert HC, Hany TF (2006) Integrated PET/CT: current applications and future directions. Radiology 238:405–422CrossRef Von Schulthess GK, Steinert HC, Hany TF (2006) Integrated PET/CT: current applications and future directions. Radiology 238:405–422CrossRef
18.
go back to reference Moore HG, Akhurst T, Larson SM, et al. (2003) A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients. J Am Coll Surg 197:22–28PubMedCrossRef Moore HG, Akhurst T, Larson SM, et al. (2003) A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients. J Am Coll Surg 197:22–28PubMedCrossRef
19.
go back to reference Potter KC, Husband JE, Houghton SL, Thomas K, Brown G (2009) Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence. Dis Colon Rectum 52:253–259PubMedCrossRef Potter KC, Husband JE, Houghton SL, Thomas K, Brown G (2009) Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence. Dis Colon Rectum 52:253–259PubMedCrossRef
20.
go back to reference Markus J, Morrissey B, deGara C, Tarulli G (1997) MRI of recurrent rectosigmoid carcinoma. Abdom Imaging 22:338–342PubMedCrossRef Markus J, Morrissey B, deGara C, Tarulli G (1997) MRI of recurrent rectosigmoid carcinoma. Abdom Imaging 22:338–342PubMedCrossRef
21.
go back to reference Messiou C, Chalmers A, Boyle K, Sagar P (2006) Surgery for recurrent rectal carcinoma: the role of preoperative magnetic resonance imaging. Clin Radiol 61:250–258PubMedCrossRef Messiou C, Chalmers A, Boyle K, Sagar P (2006) Surgery for recurrent rectal carcinoma: the role of preoperative magnetic resonance imaging. Clin Radiol 61:250–258PubMedCrossRef
22.
go back to reference Tan PL, Chan CL, Moore NR (2005) Radiological appearances in the pelvis following rectal cancer surgery. Clin Radiol 60:846–855PubMedCrossRef Tan PL, Chan CL, Moore NR (2005) Radiological appearances in the pelvis following rectal cancer surgery. Clin Radiol 60:846–855PubMedCrossRef
23.
go back to reference Robinson P, Carrington BM, Swindell R, Shanks JH, O’dwyer ST (2002) Recurrent or residual pelvic bowel cancer: accuracy of MRI local extent before salvage surgery. Clin Radiol 57:514–522PubMedCrossRef Robinson P, Carrington BM, Swindell R, Shanks JH, O’dwyer ST (2002) Recurrent or residual pelvic bowel cancer: accuracy of MRI local extent before salvage surgery. Clin Radiol 57:514–522PubMedCrossRef
24.
go back to reference Brown G, Drury AE, Cunningham D, Husband JE (2003) CT detection of hydronephrosis in resected colorectal cancer: a predictor of recurrent disease. Clin Radiol 58:137–142PubMedCrossRef Brown G, Drury AE, Cunningham D, Husband JE (2003) CT detection of hydronephrosis in resected colorectal cancer: a predictor of recurrent disease. Clin Radiol 58:137–142PubMedCrossRef
25.
go back to reference Lambregts DM, Cappendijk VC, Maas M, Beets GL, Beets-Tan RG (2011) Value of MRI and diffusion-weighted MRI for the diagnosis of locally recurrent rectal cancer. Eur Radiol 21:1250–1258PubMedCrossRef Lambregts DM, Cappendijk VC, Maas M, Beets GL, Beets-Tan RG (2011) Value of MRI and diffusion-weighted MRI for the diagnosis of locally recurrent rectal cancer. Eur Radiol 21:1250–1258PubMedCrossRef
26.
go back to reference Kim DJ, Kim JH, Lim JS, et al. (2010) Restaging of rectal cancer with MR imaging after concurrent chemotherapy and radiation therapy. Radiographics 30:503–516PubMedCrossRef Kim DJ, Kim JH, Lim JS, et al. (2010) Restaging of rectal cancer with MR imaging after concurrent chemotherapy and radiation therapy. Radiographics 30:503–516PubMedCrossRef
27.
go back to reference Kim SH, Lee JM, Hong SH, et al. (2009) Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology 253:116–125PubMedCrossRef Kim SH, Lee JM, Hong SH, et al. (2009) Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology 253:116–125PubMedCrossRef
28.
go back to reference Barbaro B, Vitale R, Leccisotti L, et al. (2010) Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy. Radiographics 30:699–716PubMedCrossRef Barbaro B, Vitale R, Leccisotti L, et al. (2010) Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy. Radiographics 30:699–716PubMedCrossRef
29.
go back to reference Sagar PM, Pemberton JH (1996) Surgical management of locally recurrent rectal cancer. Br J Surg 83:293–304PubMedCrossRef Sagar PM, Pemberton JH (1996) Surgical management of locally recurrent rectal cancer. Br J Surg 83:293–304PubMedCrossRef
30.
go back to reference Lopez-Kostner F, Fazio VW, Vignali A, Rybicki LA, Lavery IC (2001) Locally recurrent rectal cancer: predictors and success of salvage surgery. Dis Colon Rectum 44:173–178PubMedCrossRef Lopez-Kostner F, Fazio VW, Vignali A, Rybicki LA, Lavery IC (2001) Locally recurrent rectal cancer: predictors and success of salvage surgery. Dis Colon Rectum 44:173–178PubMedCrossRef
31.
go back to reference Belfiore G, Tedeschi E, Ronza FM, et al. (2009) CT-guided radiofrequency ablation in the treatment of recurrent rectal cancer. Am J Roentgenol 192:137–141CrossRef Belfiore G, Tedeschi E, Ronza FM, et al. (2009) CT-guided radiofrequency ablation in the treatment of recurrent rectal cancer. Am J Roentgenol 192:137–141CrossRef
32.
go back to reference Green SH, Khatri VP, McGahan JP (2008) Radiofrequency ablation as salvage therapy for unresectable locally recurrent rectal cancer. J Vasc Interv Radiol 19:454–458PubMedCrossRef Green SH, Khatri VP, McGahan JP (2008) Radiofrequency ablation as salvage therapy for unresectable locally recurrent rectal cancer. J Vasc Interv Radiol 19:454–458PubMedCrossRef
33.
go back to reference Lefevre JH, Parc Y, Lewin M, et al. (2008) Radiofrequency ablation for recurrent pelvic cancer. Colorectal Dis 10:781–784PubMedCrossRef Lefevre JH, Parc Y, Lewin M, et al. (2008) Radiofrequency ablation for recurrent pelvic cancer. Colorectal Dis 10:781–784PubMedCrossRef
Metadata
Title
Local colorectal cancer recurrence: pelvic MRI evaluation
Authors
A. Colosio
P. Fornès
P. Soyer
M. Lewin
M. Loock
C. Hoeffel
Publication date
01-02-2013
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 1/2013
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-012-9891-5

Other articles of this Issue 1/2013

Abdominal Radiology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.